Zhaolin W. Sun
Dalian, 116044, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Isoginkgetin as a novel USP8 inhibitor discovered by structure-based virtual screening exerts anticancer effects in ovarian cancer.
Journal: Biochemical and biophysical research communications
Published: October 29, 2025
SIRT2-mediated deacetylation activates USP22 catalytic function for PD-L1 protein stabilization and tumor immune escape.
Journal: The Journal of clinical investigation
Published: July 22, 2025
Discovery of Baicalein as a Novel Ubiquitin-Specific Protease 21 Inhibitor for the Treatment of Hepatocellular Carcinoma.
Journal: Phytotherapy research : PTR
Published: December 02, 2024
Hepatocyte growth factor promotes melanoma metastasis through ubiquitin-specific peptidase 22-mediated integrins upregulation.
Journal: Cancer letters
Published: January 22, 2024
Ubiquitin-specific peptidase 22 controls integrin-dependent cancer cell stemness and metastasis.
Journal: iScience
Published: January 09, 2024
Discovery of selective and potent USP22 inhibitors via structure-based virtual screening and bioassays exerting anti-tumor activity.
Journal: Bioorganic chemistry
Published: July 03, 2023
Ubiquitin-specific peptidase 22 controls integrin-dependent cancer cell stemness and metastasis.
Journal: Research square
Published: July 03, 2023
Integrins in human hepatocellular carcinoma tumorigenesis and therapy.
Journal: Chinese medical journal
Published: February 27, 2023
ATXN3 deubiquitinates YAP1 to promote tumor growth.
Journal: American journal of cancer research
Published: February 12, 2023
CRISPR screening identifies the deubiquitylase ATXN3 as a PD-L1-positive regulator for tumor immune evasion.
Journal: The Journal of clinical investigation
Published: December 02, 2022
A deubiquitination module essential for Treg fitness in the tumor microenvironment.
Journal: Science advances
Published: November 25, 2022
Last Updated: 09/26/2026